CRP and COVID-19: Consequently, in the present study, CRP levels were quantified, as well as other COVID-19 severity markers in hospitalized patients, in order to analyze the inflammatory response during the 48 h after receiving whether standard treatment alongside tocilizumab in severe patients, or standard treatment without tocilizumab in nonsevere patients.